Results 161 to 170 of about 27,854 (272)

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He   +4 more
wiley   +1 more source

Alzheimer's Disease: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu   +4 more
wiley   +1 more source

Multitarget Bistatic MIMO RADAR

open access: yes
This paper is concerned with the investigation of the bistatic MIMO radar for estimating various multitarget parameters of interest in the presence of clutter and noise.
Dar, Nadeem, Manikas, Athanassios
core  

Multitarget tracking through conditional probability estimation

open access: yes, 2012
Multitarget tracking is a challenging problem with a wide range of applications. Often this problem is approached through a tracking-by-detection framework in which a classifier is trained to distinguish the target of interest from all other objects. The
Aeschliman, Chad M
core  

Atherosclerosis: From Pathogenesis to Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 11, November 2026.
The diagram outlines the core mechanisms driving atherosclerosis, including endothelial dysfunction, inflammatory responses, phenotypic switching of smooth muscle cells, and the gut–vascular axis. It also presents the corresponding therapeutic approaches now under development, such as gene therapies, immunotherapies, and nanotechnology platforms ...
Enge Zhou   +9 more
wiley   +1 more source

Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang   +15 more
wiley   +1 more source

The Multitarget/Multisensor Tracking Problem

open access: yes, 1995
This report briefly reproduces the derivation of this formulation. No attempt is made to solve the multitarget/multisensor tracking and multisensor data fusion problems here.
Huub De Waard, Er Toet, Alexander Toet
core  

Polypharmacological target-aware molecule generation. [PDF]

open access: yesBioinformatics
Wu K   +10 more
europepmc   +1 more source

Dual Gut Microbiota‐Dependent Mechanisms Underlying the Anti‐Atherosclerotic Effect of Tilianin

open access: yesMedComm, Volume 7, Issue 11, November 2026.
(A) Tilianin reshapes the gut microbiota by increasing Bacteroidota, Akkermansia muciniphila, short‐chain fatty acids, and gut‐barrier integrity, while reducing Firmicutes, TMA, and TMAO. Gut microbial enzymes transform tilianin into acacetin and acacetin‐7‐O‐glucuronide.
Xuli Ruan   +13 more
wiley   +1 more source

Correction to “Development of Cytotoxic GW7604-Zeise’s Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells”

open access: yes
Correction to “Development of Cytotoxic GW7604-Zeise’s Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor ...
Hristo P. Varbanov (1764715)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy